[dbSelect] Could not connect to DB: 1040: Too many connectionsCould not execute 'SELECT r_filename, r_embargoed, UNIX_TIMESTAMP(r_pub_release_date) as rel_date FROM pressrelease WHERE r_id = 166866' on database eurekalert:
2002: Can't connect to local MySQL server through socket '/tmp/mysql.sock' (2) Patrick M. O'Connor, Ph.D., Selexagen Therapeutics Could not connect to DB: 1040: Too many connectionsCould not execute 'UPDATE multimedia SET m_hits = m_hits+ 1, m_total_hits = m_total_hits+ 1, m_pub_hits = m_pub_hits+ 1, m_total_pub_hits = m_total_pub_hits+ 1 WHERE m_id = 24839' on database eurekalert:
2002: Can't connect to local MySQL server through socket '/tmp/mysql.sock' (2)
[ Back to EurekAlert! ]

Contact: Tara Yates
tara.yates@aacr.org
267-646-0558
American Association for Cancer Research

Patrick M. O'Connor, Ph.D., Selexagen Therapeutics

Caption: Patrick M. O'Connor, Ph.D., is chief scientific officer of Selexagen Therapeutics and editorial board member for Cancer Research.

Credit: Patrick M. O'Connor, Ph.D.

Usage Restrictions: None

Related news release: Double-therapy approach effectively inhibited brain cancer recurrence


[ Back to EurekAlert! ]